UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Meditoxin’s future uncertain, even as final verdict nears
A recent series of development over Medytox’s botulinum toxin is making it ...
by Jeong Sae-im
|
2020-05-25 14:38
라인
Fall in new Covid-19 cases hampers developing treatment
Local drug companies are making an all-out effort to increase sites for cli...
by Jeong Sae-im
|
2020-05-22 17:31
라인
[Exclusive] Thailand recalls Medytox’s botulinum toxin
The Thai government not only suspended the sale of Meditoxin, a botulinum t...
by Jeong Sae-im
|
2020-05-21 12:33
라인
Plastic surgeons plead for mercy in nixing Meditoxin's license
Plastic surgeons and dermatologists have asked the regulator to reconsider ...
by Jeong Sae-im
|
2020-05-20 15:40
라인
‘Speed of Covid-19 vaccine development unprecedentedly fast’
With the world’s collaboration to fight the new coronavirus pandemic, resea...
by Jeong Sae-im
|
2020-05-18 17:04
라인
Medytox’s earnings plummet amid lawsuit against Daewoong
Medytox, the nation’s largest botulinum toxin maker by market share, suffer...
by Jeong Sae-im
|
2020-05-18 11:33
라인
[News Focus] Will Sanofi’s abrupt drop of diabetes study hurt commercial value of Hanmi drug?
Hanmi Pharmaceutical’s diabetes drug candidate efpeglenatide, which had led...
by Jeong Sae-im
|
2020-05-15 13:14
라인
Why did Kolon change Invossa contract manufacturer to Lonza?
Prosecutors have revealed Kolon Life Science had to change contract manufac...
by Jeong Sae-im
|
2020-05-14 12:03
라인
‘Sarpogrelate beneficial for elderly diabetic patients using antiplatelet agent’
Daewoong Pharmaceutical has said it would promote sarpogrelate, which repor...
by Jeong Sae-im
|
2020-05-12 17:32
라인
Shinpoong, Bukwang stocks jump on Covid-19 drug candidates
Shares of two Korean pharmaceutical companies have shot up since the first ...
by Jeong Sae-im
|
2020-05-11 12:03
라인
Daewoong’s BTX sales growth offset by lawsuit expenses
Daewoong Pharmaceutical earned 13.6 billion won ($11.1 million) by exportin...
by Jeong Sae-im
|
2020-05-08 12:01
라인
Cellivery sure to win licensing deal with top pharma company
“A global pharmaceutical company is conducting a verification test on thera...
by Jeong Sae-im
|
2020-05-07 11:27
라인
Anticipation for Korean BTX approval in China grows strong
The pharmaceutical industry is closely watching whether a Korean botulinum ...
by Jeong Sae-im
|
2020-05-06 11:53
라인
Korean drugmakers’ Q1 earnings rose despite Covid-19
Leading domestic pharmaceutical companies recorded robust earnings in the f...
by Jeong Sae-im
|
2020-05-01 14:45
라인
Kolon to return $12.3 million upfront payment to Mundipharma
Kolon Life Science said it would return 15 billion won ($12.3 million) upfr...
by Jeong Sae-im
|
2020-05-01 11:23
라인
Court rejects Medytox’ request to stop administrative order on BTX suspension
A local court has turned down Medytox’s appeal for suspending the execution...
by Jeong Sae-im
|
2020-04-29 17:11
라인
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’
SillaJen said a combination of its oncolytic viral therapy Pexa-Vec (JX-594...
by Jeong Sae-im
|
2020-04-28 17:35
라인
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate
Genexine said its investigational DNA vaccine for cervical cancer has impro...
by Jeong Sae-im
|
2020-04-28 14:48
라인
Kolon begins testing gene therapy for neuropathic pain in US
Kolon Life Science said Monday it has started the administration of an expe...
by Jeong Sae-im
|
2020-04-27 16:18
라인
Reform panel tells regulator to retain consigned bioequivalence tests
The government had planned to phase out “consigned bioequivalence test syst...
by Jeong Sae-im
|
2020-04-27 13:38
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top